Methodist Health System
methodisthealth.orgTotal trials
167
Active
38
Phase 3
2
Total enrollment
4,863,460
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| pneumoniae bacteremia therapy | — | — | — | — | — | 1 |
Next readouts
- 2026-06-23
Top conditions
- Trauma7
- COVID-197
- Obesity4
- Liver Diseases4
- Cirrhosis3
- Gastro-Intestinal Disorder3
- Pancreas Cancer2
- Gastrointestinal Disease2
Frequently asked questions about Methodist Health System
- How many clinical trials does Methodist Health System have on ClinicalTrials.gov?
- Methodist Health System is listed as the lead sponsor on 167 clinical trials in ClinicalTrials.gov, 38 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Methodist Health System's trials are in Phase 3?
- 2 of Methodist Health System's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Methodist Health System focus on?
- Methodist Health System's most-studied conditions on ClinicalTrials.gov are Trauma, COVID-19, Obesity, Liver Diseases, Cirrhosis.
- When are Methodist Health System's next clinical trial readouts?
- Methodist Health System has 1 upcoming primary-completion readout tracked here; the soonest is “Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections”, expected around 2026-06-23.